These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12660014)

  • 1. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy induced reversible posterior leukoencephalopathy syndrome.
    Connolly RM; Doherty CP; Beddy P; O'Byrne K
    Lung Cancer; 2007 Jun; 56(3):459-63. PubMed ID: 17316891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.
    Thatcher N; Jayson G; Bradley B; Ranson M; Anderson H
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-6-S8-12. PubMed ID: 9207309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
    Neubauer MA; Reynolds CH; Joppert MG; Whitaker T; Ghaddar H; Marsland TA; Asmar L
    Clin Lung Cancer; 2005 Jan; 6(4):245-9. PubMed ID: 15694017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine (Gemzar) in non-small cell lung cancer.
    Manegold C
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):345-60. PubMed ID: 15161434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
    Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
    Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ
    J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of gemcitabine in lung cancer.
    Bunn PA
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-1. PubMed ID: 9207307
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation in NSCLC: focus on the role of gemcitabine.
    Choy H
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):38-42. PubMed ID: 15339058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for advanced non-small cell lung cancer (NSCLC).
    Manegold C
    Lung Cancer; 2002 Dec; 38 Suppl 3():S47-50. PubMed ID: 12468145
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemcitabine in non-small cell lung cancer.
    Sørensen JB
    Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
    Ceribelli A; Gridelli C; De Marinis F; Fabi A; Gamucci T; Cortesi E; Barduagni M; Antimi M; Maione P; Migliorino MR; Giannarelli D; Cognetti F
    Cancer; 2003 Jul; 98(2):337-43. PubMed ID: 12872354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
    Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
    Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.